Ofatumumab Monotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Final Results From a Pivotal Study

Haematologica - Italy
doi 10.3324/haematol.2014.121459
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Azacitidine in Fludarabine-Refractory Chronic Lymphocytic Leukemia: A Phase II Study

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

R-Dhap Is Effective in Fludarabine-Refractory Chronic Lymphocytic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2016English

Treatment-Related Acute Myeloid Leukemia in a Chronic Lymphocytic Leukemia Patient: Role of Fludarabine?

Therapeutic Advances in Hematology
Hematology
2015English

Refractory Chronic Lymphocytic Leukemia – New Therapeutic Strategies

Oncotarget
Oncology
2010English

Five‐year Survival Follow‐up of a Phase III Randomised Trial Comparing Ofatumumab Versus Physicians' Choice for Bulky Fludarabine‐refractory Chronic Lymphocytic Leukaemia: A Short Report

British Journal of Haematology
Hematology
2020English

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy for Chronic Lymphocytic Leukemia

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

The Role of Ofatumumab in the Treatment of Chronic Lymphocytic Leukemia Resistant to Previous Therapies

Journal of Blood Medicine
Hematology
2010English

Real World Outcomes of Obinutuzumab Monotherapy in Patients With Chronic Lymphocytic Leukemia

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy